Form 4 for TGTX TG THERAPEUTICS, INC.
Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-12 · accession 0001437749-25-020546 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-16 | 2025-06-13 | TGTX | Echelard Yann | Dir | S - Sale | $36.94 | -10.0K | 228.8K | -4% | -$369.4K | |
| 2025-06-16 | 2025-06-12 | TGTX | Echelard Yann | Dir | A - Grant | $0.00 | +14.7K | 238.8K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-13 | S | D | 10,000 | $36.94 | 228,816 | D | — | — | (F3) These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations. (F4) Includes a weighted average price for shares sold in multiple transactions at prices ranging from $36.93 through $36.96, inclusive. Mr. Echelard undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Includes shares of restricted Common Stock, which vest over various time periods. |
| 2 | Common | Common Stock | 2025-06-12 | A | A | 14,718 | $0.00 | 238,816 | D | — | — | (F1) Reflects a grant of restricted shares that will vest on June 12, 2026. (F2) Includes shares of restricted Common Stock, which vest over various time periods. |